A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF TIDEGLUSIB, AN ORALLY ADMINISTERED GSK-3 BETA INHIBITOR, IN THE TREATMENT OF ADOLESCENTS WITH ASD Journal Articles

Overview
Research
Identity
Additional Document Info
View All

authors

Anagnostou, Evdokia
Bennett, Teresa
Thorpe, Kevin
Nicolson, Rob

status

published

publication date

October 2018

has subject area

11 Medical and Health Sciences (FoR)
17 Psychology and Cognitive Sciences (FoR)
Developmental & Child Psychology (Science Metrix)

published in

Journal of the American Academy of Child and Adolescent Psychiatry Journal